Insider · CIK 0001815426
Thomas Ciulla
Files at CLSD (Clearside Biomedical, Inc.), VRDN (Viridian Therapeutics, Inc.\DE). First filing Jan 11, 2023, latest Jan 20, 2023.
In brief
Thomas Ciulla files SEC Form 4 as officer at CLSD (Clearside Biomedical, Inc.), and also at VRDN (Viridian Therapeutics, Inc.\DE). Since Jan 11, 2023, Thomas Ciulla has reported 0 open-market buys worth $0 and 2 open-market sells worth $24k, the latest filed on Jan 20, 2023.
A track record needs three past buys with six months of prices behind them; Thomas Ciulla has 0, so none is measured yet.
The newest scored trade: sold $20k of CLSD on Jan 20, 2023, filed Jan 20, 2023, scored 10 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Clearside Biomedical, Inc. | $20k 13,700 shares | -4% | - | |
| 10Weak | Clearside Biomedical, Inc. | $3,515 2,170 shares | -1% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | VRDN Viridian Therapeutics, Inc.\DE | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 7, 2024 |
| Jan 20, 2023 | CLSD Clearside Biomedical, Inc. | SOpen-market sale Common Stock10b5-1 | -13,700 | $1.47 | $20k | 291,890 | Jan 20, 2023 |
| Jan 10, 2023 | CLSD Clearside Biomedical, Inc. | SOpen-market sale Common Stock10b5-1 | -2,170 | $1.62 | $3,515 | 305,590 | Jan 11, 2023 |
| Jun 30, 2022 | CLSD Clearside Biomedical, Inc. | AGrant or award Common Stock | +5,000 | $1.25 | $6,250 | 302,760 | Jan 6, 2023 |
| Dec 31, 2022 | CLSD Clearside Biomedical, Inc. | AGrant or award Common Stock | +5,000 | $0.95 | $4,750 | 307,760 | Jan 6, 2023 |
| Jan 4, 2023 | CLSD Clearside Biomedical, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +187,500 | $0.00 | $0 | 187,500 | Jan 6, 2023 |
Questions about Thomas Ciulla
Answered from the filings on this page, as of the latest one.
Is Thomas Ciulla buying or selling?
Not in the last 12 months. Thomas Ciulla's latest open-market trade on SEC Form 4 was sold $20k of CLSD on Jan 20, 2023.
How did Thomas Ciulla's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Ciulla has 0.
Where does Thomas Ciulla file Form 4?
Thomas Ciulla has filed Form 4 at CLSD (Clearside Biomedical, Inc.) as Chief Medical Officer; VRDN (Viridian Therapeutics, Inc.\DE) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.